Parvovirus B19 infection in the immunocompromised host

Area of Science:

• Virology
• Immunology
• Hematology

Background:

• Human parvovirus B19 targets erythroid progenitor cells, crucial for red blood cell production.
• Immunocompromised individuals, including those with SCID, AIDS, or post-transplant, are at high risk for severe B19 infection.
• B19 infection can lead to persistent pure red cell aplasia in immunocompromised patients.

Purpose of the Study:

• To provide an overview of parvovirus B19 infection in immunocompromised patients.
• To summarize current knowledge on clinicopathologic features, pathobiology, and diagnosis.
• To highlight the importance of recognizing B19 manifestations in specific patient groups.

Main Methods:

• Review of existing literature on parvovirus B19 in immunocompromised hosts.
• Analysis of diagnostic methods, including bone marrow biopsy and in situ hybridization.
• Correlation of clinical presentation with hematologic and immunologic status.

Main Results:

• Parvovirus B19 infection can manifest with a broad spectrum of clinical and hematologic findings.
• Identification of viral inclusions in bone marrow biopsies is a key diagnostic indicator.
• In situ hybridization confirms B19 infection and aids in assessing anemia.
• Immunocompromised status significantly influences the severity and outcome of B19 infection.

Conclusions:

• Pathologists must be aware of parvovirus B19's potential to cause severe anemia in immunocompromised patients.
• Accurate diagnosis relies on integrating clinical, hematologic, and laboratory findings.
• Timely diagnosis and management are essential for improving outcomes in B19-infected immunocompromised individuals.